Lactate dehydrogenase as a hematopoietic stem cell mobilization biomarker in autologous transplantation

被引:0
|
作者
Colunga-Pedraza, Perla R. [1 ]
Irabien-Zuniga, Mariela [1 ]
Rodriguez-Roque, Carlos Saul [1 ]
Cruz, Carlos de la Cruz-de la [1 ]
Leon, Andres Gomez-De [1 ]
Santana-Hernandez, Paola [1 ]
Jaime-Perez, Jose Carlos [1 ]
Mancias-Guerra, Consuelo [1 ]
Gomez-Almaguer, David [1 ]
机构
[1] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Francisco I Madero Ave, Mitras Ctr, Monterrey, Nuevo Leon, Mexico
关键词
Stem cells; Autologous transplantation; Hematopoietic stem cell mobilization; Lactate dehydrogenase; COLONY-STIMULATING FACTOR; PERIPHERAL-BLOOD; G-CSF; YIELD; ISOENZYMES; AGE;
D O I
10.1016/j.htct.2022.07.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Pre-apheresis peripheral blood CD34+ cell count (PBCD34+) is the most important predictor of good cell mobilization before hematopoietic stem cell transplantation, albeit flow cytometry is not always immediately available. Identification of surrogate markers can be useful. The CD34+ cells proliferate after mobilization, resulting in elevated lactate dehydrogenase (LDH) activity and correlating with the PBCD34+ count.Objective: To determine the LDH cut-off value at which adequate CD34+ cell mobilization is achieved and its diagnostic yield. Materials and methods: A total of 103 patients who received an autologous stem cell transplantation (ASCT) between January 2015 and January 2020 were included. Demographic and laboratory characteristics were obtained, including complete blood count, pre-apheresis PBCD34+ and LDH levels. Receiver operating characteristic (ROC) curves were performed to identify the optimal serum LDH activity cut-off points for > 2 and >= 4 x 10(6) cells/kg post mobilization CD34+ count and their diagnostic yield.Results: A post-mobilization serum LDH cut-off value of 462 U/L yielded a sensitivity (Se) = 86.8% (positive predictive value [PPV] = 72.7%), a pre-and post-mobilization serum LDH difference cut-off value of 387 U/L, an Se = 45.7% (PPV = 97%) and an LDH ratio of 2.46, with an Se = 47.1% (PPV = 97%) for an optimal mobilization count (CD34+ >= 4 x 10(6)).Conclusion: The LDH measurement represents a fast and affordable way to predict PBCD34+ mobilization in cases where flow cytometry is not immediately available. According to the LDH diagnostic yield, it could be used as a surrogate marker in transplant centers, supporting the CD34+ count, which remains the gold standard.(c) 2022 Associacao Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:435 / 441
页数:7
相关论文
共 50 条
  • [31] Autologous hematopoietic stem cell transplantation in autoimmune diseases
    Annaloro, Claudio
    Onida, Francesco
    Deliliers, Giorgio Lambertenghi
    EXPERT REVIEW OF HEMATOLOGY, 2009, 2 (06) : 699 - 715
  • [32] Autologous hematopoietic stem cell transplantation for mantle cell lymphoma
    Vose, JM
    Bierman, PJ
    Weisenburger, DD
    Lynch, JC
    Bociek, G
    Chan, WC
    Greiner, TC
    Armitage, JO
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2000, 6 (06) : 640 - 645
  • [33] Vitiligo Following Autologous Hematopoietic Stem Cell Transplantation
    Nguyen, James
    Singh, Navdeep
    Afifi, Salma
    Giralt, Sergio
    Lacouture, Mario E.
    Busam, Klaus J.
    Hassoun, Hani
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 (04): : E171 - E173
  • [34] Autologous hematopoietic stem cell transplantation for systemic sclerosis
    Nature Clinical Practice Rheumatology, 2008, 4 (4): : 173 - 174
  • [35] Autologous Hematopoietic Stem Cell Transplantation in Neuromyelitis Optica
    Burton, Jodie
    Storek, Jan
    Costello, Fiona
    Duggan, Peter
    Metz, Luanne
    NEUROLOGY, 2013, 80
  • [36] Autologous hematopoietic stem cell transplantation in Clarkson disease
    Druey, Kirk M.
    Eisch, Robin
    Cunningham-Rundles, Charlotte
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2023, 11 (01): : 347 - 349
  • [37] Autologous hematopoietic stem cell transplantation for autoimmune diseases
    Gratwohl, A
    Passweg, J
    Bocelli-Tyndall, C
    Fassas, A
    van Laar, JM
    Farge, D
    Andolina, M
    Arnold, R
    Carreras, E
    Finke, J
    Kötter, I
    Kozak, T
    Lisukov, I
    Löwenberg, B
    Marmont, A
    Moore, J
    Saccardi, R
    Snowden, JA
    van den Hoogen, F
    Wulffraat, NM
    Zhao, XW
    Tyndall, A
    BONE MARROW TRANSPLANTATION, 2005, 35 (09) : 869 - 879
  • [38] Autologous hematopoietic stem cell transplantation for autoimmune diseases
    A Gratwohl
    J Passweg
    C Bocelli-Tyndall
    A Fassas
    J M van Laar
    D Farge
    M Andolina
    R Arnold
    E Carreras
    J Finke
    I Kötter
    T Kozak
    I Lisukov
    B Löwenberg
    A Marmont
    J Moore
    R Saccardi
    J A Snowden
    F van den Hoogen
    N M Wulffraat
    X W Zhao
    A Tyndall
    Bone Marrow Transplantation, 2005, 35 : 869 - 879
  • [39] Endothelial dysfunction in autologous hematopoietic stem cell transplantation
    Diaz-Ricart, Maribel
    Carbo, Carla
    Palomo, Mirta
    Fernandez-Aviles, Francese
    Rovira, Montse
    Escolar, Gines
    Carreras, Enric
    BLOOD, 2007, 110 (11) : 289B - 289B
  • [40] Autologous hematopoietic stem cell transplantation for autoimmune diseases
    Tyndall, A
    Daikeler, T
    ACTA HAEMATOLOGICA, 2005, 114 (04) : 239 - 247